- Home
- IMNN vs ISPO Comparison
IMNN vs ISPO Comparison
Compare IMNN & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- ISPO
- Stock Information
- Founded
- IMNN 1982
- ISPO 2010
- Country
- IMNN United States
- ISPO United States
- Employees
- IMNN N/A
- ISPO N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- ISPO Blank Checks
- Sector
- IMNN Health Care
- ISPO Finance
- Exchange
- IMNN Nasdaq
- ISPO Nasdaq
- Market Cap
- IMNN 12.1M
- ISPO 49.5M
- IPO Year
- IMNN 1985
- ISPO N/A
- Fundamental
- Price
- IMNN $0.80
- ISPO $3.50
- Analyst Decision
- IMNN Buy
- ISPO
- Analyst Count
- IMNN 2
- ISPO 0
- Target Price
- IMNN $14.00
- ISPO N/A
- AVG Volume (30 Days)
- IMNN 2.3M
- ISPO 30.3K
- Earning Date
- IMNN 08-13-2025
- ISPO 08-12-2025
- Dividend Yield
- IMNN N/A
- ISPO N/A
- EPS Growth
- IMNN N/A
- ISPO N/A
- EPS
- IMNN N/A
- ISPO N/A
- Revenue
- IMNN N/A
- ISPO $265,499,000.00
- Revenue This Year
- IMNN N/A
- ISPO N/A
- Revenue Next Year
- IMNN N/A
- ISPO $148.67
- P/E Ratio
- IMNN N/A
- ISPO N/A
- Revenue Growth
- IMNN N/A
- ISPO N/A
- 52 Week Low
- IMNN $0.37
- ISPO $3.11
- 52 Week High
- IMNN $3.65
- ISPO $9.31
- Technical
- Relative Strength Index (RSI)
- IMNN 41.12
- ISPO 42.79
- Support Level
- IMNN $0.70
- ISPO $3.32
- Resistance Level
- IMNN $0.82
- ISPO $3.81
- Average True Range (ATR)
- IMNN 0.10
- ISPO 0.44
- MACD
- IMNN -0.05
- ISPO -0.07
- Stochastic Oscillator
- IMNN 11.49
- ISPO 11.39
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.